Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
292.16
+1.37 (0.47%)
Aug 12, 2025, 11:31 AM - Market open
Elevance Health Revenue
Elevance Health had revenue of $49.78B in the quarter ending June 30, 2025, with 14.04% growth. This brings the company's revenue in the last twelve months to $189.25B, up 10.21% year-over-year. In the year 2024, Elevance Health had annual revenue of $176.81B with 3.19% growth.
Revenue (ttm)
$189.25B
Revenue Growth
+10.21%
P/S Ratio
0.35
Revenue / Employee
$1,816,257
Employees
104,200
Market Cap
65.79B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 176.81B | 5.47B | 3.19% |
Dec 31, 2023 | 171.34B | 14.74B | 9.41% |
Dec 31, 2022 | 156.60B | 17.96B | 12.95% |
Dec 31, 2021 | 138.64B | 16.78B | 13.76% |
Dec 31, 2020 | 121.87B | 17.66B | 16.94% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ELV News
- 4 days ago - 3 SWANs On Sale - Seeking Alpha
- 4 days ago - Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts - Seeking Alpha
- 14 days ago - Elevance Health Board Welcomes Steve Collis as New Director, Reflecting Ongoing Commitment to Governance Excellence - Business Wire
- 18 days ago - Centene, Cigna, Others Drop As Molina's Results Rattle Sector - Benzinga
- 18 days ago - Elevance Health: CEO Buys As CareBridge Drives Strong Growth - Seeking Alpha
- 21 days ago - Study Finds Digital Asthma Program Significantly Improves Symptom Control in Adults - Business Wire
- 25 days ago - S&P 500 Gains and Losses Today: Pepsi Stock Turns Higher; Elevance Health Tumbles - Investopedia
- 25 days ago - Top Stock Movers Now: PepsiCo, Elevance Health, CSX, and More - Investopedia